Endomorphin-1 is a novel endogenous opioid peptide with high affinity and selectivity for the m-opioid receptor. Earlier results have shown that it causes antinociception in different pain tests, but its effect is short-lasting. The purpose of the present study was to investigate the antinociceptive potency of continuously administered endomorphin-1 on carrageenan-induced thermal hyperalgesia by means of a paw withdrawal test in awake rats. The possible interaction between endomorphin-1 and the C-terminal octapeptide of the novel endogenous peptide nocistatin (bPNP-3-8P) was examined in the same experimental set-up. Continuous administration of endomorphin-1 (0.1, 0.3, 1 or 2 mg/min for 60 min) did not influence the paw withdrawal latencies of the normal paws. On the inflamed side, endomorphin-1 dosedependently decreased the thermal hyperalgesia during continuous administration. The cessation of administration resulted in a gradual decrease in the antinociceptive effect of endomorphin-1. bPNP-3-8P (0.003-30 mg, administered cumulatively) significantly decreased the heat hyperalgesia at higher doses (3 and 30 mg). Continuous administration of bPNP-3-8P (0.03, 0.1 and 1 mg/min) did not potentiate the antinociceptive effect of endomorphin-1; instead, it even shortened the duration of its effect. The results demonstrate that continuous administration of endomorphin-1 is an effective method of inhibiting thermal hyperalgesia in rats. Furthermore, the fragment bPNP-3-8P itself has low antinociceptive potency and does not potentiate the antinociceptive effect of endomorphin-1 under these circumstances. q
Introduction
Chronic pain caused by inflammation is known to be clinically associated with hyperalgesia. Carrageenaninduced inflammatory hyperalgesia has been widely used as an animal model to study the mechanism of nociception and to screen for anti-inflammatory drugs. It has been shown that peripheral inflammatory hyperalgesia is due, at least in part, to the enhancement of synaptic transmission mediated by substance P and excitatory amino acids in the spinal dorsal horn (Ren et al., 1992; Traub, 1996) . The dorsal horn constitutes the first relay station for incoming somatosensory information, and many substances (including peptides) are involved in the modulation of pain information at this level. Two tetrapeptides, endomorphin-1 and endomorphin-2 (Tyr-Pro-Trp-Phe-NH 2 and Tyr-Pro-Phe-Phe-NH 2 , respectively), have been identified as endogenous ligands of the m-opioid receptors (Zadina et al., 1997) . They activate these receptors with high affinity and selectivity (Zadina et al., 1997) . Since morphine and other opiates produce their analgesic effects primarily through the m-opioid receptor, endomorphins may represent a class of endogenous opioids that have therapeutic potential. The presence of a dense aggregation of endomorphin-like immunoreactive elements in the superficial dorsal horns of the medulla and spinal cord indicates that endomorphins are likely to modulate nociceptive transmission (Martin-Schild et al., 1997; Wu et al., 1999) . There is behavioural evidence that these peptides produce potent analgesia in rodents under different pain conditions such as acute, inflammatory and neuropathic pain models (Horvath, 2000) . The data 
